Insight Pharma Reports Announces Biomarkers in Amyotrophic Lateral Sclerosis Report

NEEDHAM, Mass. - Aug. 22, 2014 - PRLog -- Insight Pharma Reports, a scientific report leader for over 15 years, released a new report on Biomarkers in Amyotrophic Lateral Sclerosis.    This report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Amyotrophic Lateral Sclerosis, Biomarkers in Amyotrophic Lateral Sclerosis captures market growth of biomarkers, advantages, disadvantages, and validation techniques.

Experts interviewed in this report include:

·         Dr. Merit Ester Cudkowicz, Chief of Neurology at Massachusetts General Hospital

·         Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers

Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured by an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.

Insight Pharma Reports also engineered a table of clinical trial information and pipeline data from multiple databases related to ALS. This table features companies, targets, clinical phases, and brief target/product descriptions.

For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/biomarkers-in-amyotro...

or contact Kerri Kelley at kkelley@healthtech.com or 781-972-1347.

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/